Kemwell Biopharma

Kemwell Biopharma company information, Employees & Contact Information

Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing. 15,000 sq. m. Kemwell facility consists of a cGMP drug substance manufacturing area with over 4500L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics from mammalian-cell culture – monoclonal antibodies, bi-specific antibodies, fusion proteins, etc. Kemwell is capable of supporting novel, bio-better and biosimilar programs’ preclinical development, clinical development, cGMP clinical manufacturing and cGMP commercial manufacturing. Kemwell, having established in 1980, had long term associations with pharma majors such as Bayer, GlaxoSmithKline, Merck KGaA, Novartis, Pfizer and others for small molecule contract mfg. and R&D. In 2016, Kemwell divested its small-molecule division to focus on biologics, leveraging its vast and rich experience. Kemwell is now a 100% biologics CDMO.
Looking for a particular Kemwell Biopharma employee's phone or email?

Kemwell Biopharma Questions

News

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing - Business Wire

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing Business Wire

Kemwell - Pharmaceutical Technology

Kemwell Pharmaceutical Technology

Kemwell - Clinical Trials Arena

Kemwell Clinical Trials Arena

RevOpsis and Kemwell Biopharma Enter into Strategic Manufacturing Partnership to Expedite Development of Novel Multispecific Biologics - PR Newswire

RevOpsis and Kemwell Biopharma Enter into Strategic Manufacturing Partnership to Expedite Development of Novel Multispecific Biologics PR Newswire

Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200 - Ocugen

Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200 Ocugen

The Rise of Biopharmaceutical Outsourcing to Indian CDMOs - BioProcess International

The Rise of Biopharmaceutical Outsourcing to Indian CDMOs BioProcess International

Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing - PR Newswire

Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing PR Newswire

Cipla JV with Manipal subsidiary and Kemwell Biopharma to develop cell therapy - Times of India

Cipla JV with Manipal subsidiary and Kemwell Biopharma to develop cell therapy Times of India

Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available - BioProcess International

Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available BioProcess International

Top Kemwell Biopharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant